Provided by Tiger Trade Technology Pte. Ltd.

ACLARION, INC

2.62
-0.0900-3.32%
Volume:26.63K
Turnover:70.36K
Market Cap:7.55M
PE:-0.34
High:2.73
Open:2.73
Low:2.61
Close:2.71
52wk High:12.03
52wk Low:1.95
Shares:2.88M
Float Shares:2.62M
Volume Ratio:0.37
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5967
EPS(LYR):-13.6087
ROE:-58.97%
ROA:-37.01%
PB:0.44
PE(LYR):-0.19

Loading ...

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as Clarity Trial Site

THOMSON REUTERS
·
Aug 20

Aclarion - Anticipates Having Initial Internal Data Readout & Expected Public Disclosure of Early Interim Results in Q4

THOMSON REUTERS
·
Aug 20

Aclarion Adds University of Arizona College of Medicine–Phoenix as Clarity Trial Site for Nociscan

Reuters
·
Aug 20

Aclarion Director Amanda M Williams Reports Purchase of 5,857 Common Shares Worth $15,989.61

Reuters
·
Aug 19

Aclarion CEO Brent Ness Reports Purchase of 5,234 Common Shares for $12,093.54

Reuters
·
Aug 17

Aclarion Says USPTO Issues Notice of Allowance for Lumbar Disc MRS Scan-Prescription Patent Application

Reuters
·
Aug 12

Aclarion Q2 FY26 Net Loss Narrows 59.27% to $2.75 Million; Revenue Rises 30.5% to $25,208

Reuters
·
Aug 06

Aclarion Announces Availability of CEO Shareholder Letter

Reuters
·
Jul 29

Aclarion Notifies Availability of Press Release on Nociscan Clinical Use Abstracts

Reuters
·
Jul 21

Aclarion Launches Market Access Program With PRIA Healthcare

MT Newswires Live
·
Jun 09

BRIEF-Aclarion Stockholders Approve All Proposals At 2026 Annual Meeting

Reuters
·
Jun 08

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

THOMSON REUTERS
·
Jun 08

Aclarion - Board Says Echo Lake Proposal Significantly Undervalues Company

THOMSON REUTERS
·
Jun 08

Press Release: Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal

Dow Jones
·
Jun 08

Press Release: Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Dow Jones
·
Jun 08

Aclarion holds annual shareholder meeting

Reuters
·
Jun 05

Aclarion signs agreement with Institute of Neuro Innovation to offer Nociscan in Los Angeles area

Reuters
·
Jun 03

Aclarion says Nociscan study links intradiscal propionic acid to immune-activated back pain subtype

Reuters
·
Jun 01

Aclarion Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
May 29

Aclarion to ‘carefully review and evaluate’ Echo Lake’s proposal

TIPRANKS
·
May 29